BEAM Alliance – Guidelines as to how antibacterial R&D could be revived and proposes specific support for SME-driven innovation in the AMR field. by mcwebmaster | Dec 21, 2017
AiCuris Initiates Clinical Development of AIC499, a Novel Resistance-Breaking Antibiotic against a Broad Range of MDR Gram-Negative Bacteria by mcwebmaster | Dec 19, 2017
CARB-X Funding Award to Advance Development of LpxC Inhibitor Antibiotic to Fight Drug Resistant by mcwebmaster | Dec 19, 2017
Merck & Co., Inc – Partnering with Local Hospitals Worldwide to Implement Antimicrobial Stewardship (AMS) Programs by mcwebmaster | Dec 19, 2017
Leveraging global surveillance data to develop rapid diagnostics: MSD & OpGen’s Collaboration by mcwebmaster | Dec 19, 2017